课题基金 / 基金详情

Canadian Leukodystrophy Conference for Patients and Families: Current and Novel therapies

Canadian Leukodystrophy Conference for Patients and Families: Current and Novel therapies
加拿大脑白质营养不良患者和家庭会议：当前和新疗法
批准号：
372816
负责人：
Bernard Geneviève
金额：
$1.46万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Miscellaneous Programs
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-08-01 至 2018-08-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=372816&lang=en
关键词：
Current Therapies Enzyme Replacement Therapy Ex Vivo Gene Therapy Family Conference Gene Editing Genetic Leukoencephalopathies In Vivo Gene Therapy Leukodystrophies Novel Therapies

项目摘要

项目成果

Bernard Geneviève的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Leukodystrophies are a group of rare disorders affecting the white matter (myelin) of the brain. Myelin serves as insulation and protection for nerve cells, allowing for normal conduction of nerve impulses. Leukodystrophies are divided in two categories,
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RNA polymerase III-related leukodystrophy: Understanding disease pathogenesis and developing novel therapeutic approaches using murine models
RNA polymerase III-related leukodystrophy: Understanding disease pathogenesis and developing novel therapeutic approaches using murine models
Unraveling the molecular basis of novel forms of hypomyelinating leukodystrophies
Unraveling the molecular basis of novel forms of hypomyelinating leukodystrophies
海外基金